Samsung Pharm Cash Flow Quality Index
Samsung Pharm cash flow quality index. Samsung Pharm (001360) has a Cash Flow Quality Index of -0.01x as of June 2025. Operating cash flow of ₩-804.23 Million is below net income of ₩63.57 Billion, suggesting accrual-heavy earnings not yet converted to cash. See 001360 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Samsung Pharm (2019–2019)
Cash flow quality index of Samsung Pharm from 2019 to 2019. Historical Cash Flow Quality Index for Samsung Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Samsung Pharm (001360) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Samsung Pharm Cash Flow Quality Index by Year (2019–2019)
Samsung Pharm cash flow quality index by year from 2019 to 2019. Year-by-year earnings quality comparison for Samsung Pharm. For the full cash flow conversion analysis, see 001360 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -0.35x | ₩-2.43 Billion | ₩6.89 Billion | — |